bioaccess® identifies, qualifies, and activates clinical trial sites across Latin America for first-in-human and early-feasibility studies. Our network spans 100+ research sites across the Latin American & Caribbean countries we serve.
Access to large patient populations with significant unmet clinical need, under full ethics-committee oversight, with ethics review timelines that vary by country and by each committee's meeting schedule, lets early-stage studies plan for first human data. Individual timelines and costs vary and are not guaranteed; data quality is maintained under ISO 14155 GCP to support eligibility for FDA acceptance under 21 CFR 812.28.
Related: Clinical trial services · Case studies · Regulatory guide